Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.279SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AE.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.214SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.284SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.351.3 (Beta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.318SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
R.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.283SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.96SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
L.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.290SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.341SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.161SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.69 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.139SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.508SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.94SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.463SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.357SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.318SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.557SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.119SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.160SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
D.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.447SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.110.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.180SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.155SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.92SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.145SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.120SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.77SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AE.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.504SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.201SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.221SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.410SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.411SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.310SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.185SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.329SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.229SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.342SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used